Drug Profile
Conjugated estrogens vaginal - Teva
Alternative Names: Bijuva; SCE ALatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Barr Laboratories
- Developer Teva Pharmaceutical Industries
- Class Estradiol congeners; Hormonal replacements; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atrophic vaginitis
Most Recent Events
- 01 Dec 2008 Registered for Vaginal atrophy in USA (Vaginal)
- 26 Apr 2005 Duramed Pharmaceuticals has received a non-approvable letter from the US FDA for Bijuva™ in Vaginal atrophy
- 04 Nov 2004 Preregistration for Vaginal atrophy in USA (Vaginal)